David Abbey
Internal Medicine · Fort Collins, CONPI 1568483196
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,075 and has fallen 98.5% since, to $16 in 2024. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$232
- Novartis$230
- AstraZeneca$199
- Boehringer Ingelheim$193
- Johnson & Johnson$176
- Pfizer$154
- plus $955 from 28 others
What the payments were for
- Food & beverage$2,06797%
- Education$733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $232 |
| Novartis | 13 | $230 |
| AstraZeneca | 13 | $199 |
| Boehringer Ingelheim | 12 | $193 |
| Johnson & Johnson | 10 | $176 |
| Pfizer | 10 | $154 |
| Alnylam Pharmaceuticals Inc. | 5 | $126 |
| AbbVie(2 entities) | 4 | $87 |
| Senseonics, Incorporated | 1 | $71 |
| Merck | 5 | $69 |
| Sunovion Pharmaceuticals Inc. | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| Lilly USA, LLC | 3 | $40 |
| Biogen | 2 | $38 |
| Astellas Pharma US Inc | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $32 |
| GE HealthCare | 1 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 1 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Radius Health, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| GSK | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$2,140 in reported general payments places this provider in the 90th percentile of 1,430 internal medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 26 | $364 |
| Atorvastatin Calcium | 32 | $259 |
| Donepezil Hcl | 18 | $257 |
| Rosuvastatin Calcium | 12 | $241 |
| Amlodipine Besylate | 25 | $116 |
| Lisinopril | 16 | $73 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fort Collins
- Gilad GordonBoulder$476K
- Kathryn PolovitzParker$403K
- Monica GrafalsAvon$401K
- Luke WebbColorado Springs$287K
- Samuel PiedadColorado Springs$154K
- Sophia AmbrusoLittleton$62K
- Kristine KuhnAurora$61K
- Kenneth OleszekDenver$60K
- Munni SelagamsettyColorado Springs$55K
- Robert KeithDenver$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.